Home » Topics » Regulatory

Regulatory
RSS

European Commission approves novel oral anticoagulant Pradaxa

March 28, 2008

FDA approves Pristiq as therapy for adults with major depressive disorder

March 3, 2008

FDA approves Luvox CR Extended-Release capsules for SAD and OCD therapy

Feb. 29, 2008

FDA approves Arcalyst for cryopyrin-associated periodic syndromes (CAPS)

Feb. 29, 2008

FDA approves Abbott's Humira for polyarticular juvenile idiopathic arthritis

Feb. 25, 2008

FDA approves Abbott's Simcor, a combination therapy for cholesterol management

Feb. 18, 2008

FDA approves Emend for Injection as part of treatment for CINV

Jan. 30, 2008

Europe authorizes expanded use of The Medicines Company's Angiox in ACS

Jan. 29, 2008

Asahi Kasei obtains approval for recombinant thrombomodulin alpha

Jan. 29, 2008

Antibacterial Gracevit receives manufacturing and marketing approval in Japan

Jan. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...